Conventus Orthopaedics, Inc. announced that it signed a definitive agreement to acquire Flower Orthopedics. The acquisition will close following completion of all closing conditions. Terms were not disclosed. Flower Orthopedics, is a market leader in sterile-packaged anatomic foot & ankle implants, allografts and diabetic wound care solutions for orthopedic surgeons and podiatrists. Conventus was first recognized for its platform proprietary nitinol CAGE™ technology to treat proximal humerus and distal radius fractures with unmatched stability and reduced complications compared to plating. Lower extremity CAGE™ implants are in development. The Flower Ortho acquisition follows Conventus’ recent acquisition of an innovative intramedullary distal fibula system from Surgical Frontiers.
Read the full article: Conventus Orthopaedics, Inc. Has Signed a Definitive Agreement to Acquire Flower Orthopedics //
Source: https://flowerortho.com/conventus-orthopaedics-inc-has-signed-a-definitive-agreement-to-acquire-flower-orthopedics